Literature DB >> 8469997

Renal clearance determination with one blood sample: improved accuracy and universal applicability by a new calculation principle.

B Bubeck1.   

Abstract

A sufficiently accurate quantification of renal function requiring only one plasma sample without an additional gamma camera study has until now only been possible in adults. A new principle has been developed that allows the universal application of known algorithms, irrespective of the clearance substance used, by normalizing the plasma concentrations with respect to individual body dimensions of adult as well as infant patients. In this respect, algorithms are established for clearance determinations using technetium-99m mercaptoacetyltriglycine which are based on steady-state studies as the reference. They allow the calculation of quantitative clearance values in infants and require the drawing of only one blood sample at any time between 25 and 40 minutes postinjection. The comparison with a combined-camera/two-plasma-sample technique performed in 46 children ranging in age from 9 days to 14 years (mean, 6.05 years) resulted in a standard deviation of 8.5% from the line of identity (r = 0.94). Moreover, this procedure also increases accuracy in adult patients, especially those with impaired renal function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8469997     DOI: 10.1016/s0001-2998(05)80064-9

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  8 in total

1.  Development and prospective evaluation of an automated software system for quality control of quantitative 99mTc-MAG3 renal studies.

Authors:  Russell D Folks; Ernest V Garcia; Andrew T Taylor
Journal:  J Nucl Med Technol       Date:  2007-03

2.  SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0.

Authors:  Andrew T Taylor; David C Brandon; Diego de Palma; M Donald Blaufox; Emmanuel Durand; Belkis Erbas; Sandra F Grant; Andrew J W Hilson; Anni Morsing
Journal:  Semin Nucl Med       Date:  2018-03-16       Impact factor: 4.446

3.  Reproducibility of technetium-99m mercaptoacetyltriglycine clearance.

Authors:  A Piepsz; M Tondeur; J Kinthaert; H R Ham
Journal:  Eur J Nucl Med       Date:  1996-02

Review 4.  Radionuclides in nephrourology, part 1: Radiopharmaceuticals, quality control, and quantitative indices.

Authors:  Andrew T Taylor
Journal:  J Nucl Med       Date:  2014-02-18       Impact factor: 10.057

5.  Decision support systems in diuresis renography.

Authors:  Andrew Taylor; Amita Manatunga; Ernest V Garcia
Journal:  Semin Nucl Med       Date:  2008-01       Impact factor: 4.446

6.  Kidney Perfusion in Contrast-Enhanced Ultrasound (CEUS) Correlates with Renal Function in Living Kidney Donors.

Authors:  Nasrin El-Bandar; Markus H Lerchbaumer; Robert Peters; Andreas Maxeiner; Katja Kotsch; Arne Sattler; Kurt Miller; Thorsten Schlomm; Bernd Hamm; Klemens Budde; Lutz Liefeldt; Thomas Fischer; Frank Friedersdorff
Journal:  J Clin Med       Date:  2022-02-01       Impact factor: 4.241

7.  Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting Peptides.

Authors:  Peter Kletting; Christiane Schuchardt; Harshad R Kulkarni; Mostafa Shahinfar; Aviral Singh; Gerhard Glatting; Richard P Baum; Ambros J Beer
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

8.  The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy.

Authors:  Rudolf A Werner; Seval Beykan; Takahiro Higuchi; Katharina Lückerath; Alexander Weich; Michael Scheurlen; Christina Bluemel; Ken Herrmann; Andreas K Buck; Michael Lassmann; Constantin Lapa; Heribert Hänscheid
Journal:  Oncotarget       Date:  2016-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.